Growth Perspectives: Key Highlights from DCAT 2024
Frost & Sullivan
APRIL 3, 2024
AbbVie introduced a customized risk-based governance model for agile and compliant operations in a highly regulated and risk-sensitive environment. A vital requirement is to successfully scale the formulation from clinical to commercial manufacturing quickly.
Let's personalize your content